Abstract
Metabolic syndrome (MS) can increase the chances of an individual developing diabetes and heart diseases, therefore, studies that demonstrate potential therapies for MS are necessary. Among these, there is supplementation with beta-alanine (²A), a promising substance in reducing the number of free radicals present in an organism with MS. Thus, the objective of this study will be to evalua…